Azithromycin use and outcomes in patients with COVID-19: an observational real-world study
Ippazio Cosimo Antonazzo(University of Bergen), Giampiero Mazzaglia(Società Italiana di Medicina Generale), Giovanni Maifredi, Carla Fornari, Giancarlo Cesana(University of Milano-Bicocca), Raffaella Pasquale(University of Milano-Bicocca), Paolo Angelo Cortesi(University of Milano-Bicocca), Shaniko Kaleci(University of Modena and Reggio Emilia), LG Mantovani(IRCCS Istituto Auxologico Italiano), Sara Conti, Andrea Silenzi(Università Cattolica del Sacro Cuore), Pietro Ferrara, Alberto Zucchi(University of Bergamo), Davide Rozza(University of Milano-Bicocca)
Cited by 11
Related Papers
Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
|The Lancet Neurology|2021|7.9k
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Infectious Diseases|2018|2k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
Global Burden of Multiple Myeloma
|JAMA Oncology|2018|631
The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the Global Burden of Disease Study 2019
|The Lancet Regional Health - Europe|2022|348